What is the recommended dose of MiraLAX (polyethylene glycol) for a 10-year-old male patient weighing 39..Ptr (39.4 kilograms)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MiraLAX Dosing for a 10-Year-Old Male Weighing 39.4 kg

For a 10-year-old male weighing 39.4 kg, the recommended dose of MiraLAX (polyethylene glycol 3350) is 17 grams (one capful or one packet) dissolved in 4-8 ounces of liquid once daily. 1

Standard Pediatric Dosing

  • The FDA-approved dose for children and adults is 17 grams of polyethylene glycol 3350 per day, which can be administered as a single daily dose 1
  • This patient weighs just under 40 kg, but at age 10 years, he falls into the standard pediatric dosing category where the adult dose of 17 grams daily is appropriate 2
  • PEG 3350 acts as an osmotic laxative with dose-dependent efficacy, making it highly effective for treating functional constipation in children 2

Administration Guidelines

  • Mix the 17-gram dose in 4-8 ounces of water, juice, coffee, or tea to improve palatability 3
  • The medication should be taken once daily, preferably at the same time each day for consistency 4
  • PEG 3350 can be used for both initial disimpaction and long-term maintenance treatment of constipation 2

Duration and Safety

  • PEG 3350 is safe for chronic use in children, with studies demonstrating safety and efficacy for up to 12 months of continuous treatment 4
  • The most common adverse effects are mild gastrointestinal complaints including diarrhea, loose stools, flatulence, and nausea 4
  • In patients predisposed to water and electrolyte imbalances, monitoring of serum electrolytes should be considered, though clinically significant electrolyte disturbances are rare 2
  • No evidence of tachyphylaxis (tolerance) develops with long-term use 4

Clinical Efficacy

  • Studies show 80-88% of patients report successful treatment with PEG 3350 at the standard 17-gram daily dose 4
  • PEG 3350 has become the laxative of first choice in international guidelines for treating functional constipation in children due to its excellent efficacy, safety profile, and patient acceptance 2, 5

Related Questions

Can Miralax (polyethylene glycol) be taken twice daily?
Does MiraLAX (polyethylene glycol) have an impact on your heart?
What is the initial treatment for acute constipation?
Is a delayed response of over an hour to Trilyte (polyethylene glycol) typical in an adult patient undergoing colonoscopy prep with a standard dosing regimen of 8 oz every 10 minutes?
What are the first-line laxatives for pediatric patients?
What are the diagnostic criteria and treatment options for a patient with suspected pancreatitis, presenting with acute abdominal pain, nausea, vomiting, and a history of gallstones, hypertriglyceridemia, or alcohol abuse?
How to manage steroid-induced hyperglycemia in a previously non-diabetic patient?
What is the likely cause of acute dyspnea in a 40-year-old male with a history of obstructive sleep apnea (OSA), childhood asthma, cigarette use, inhaled vaporized nicotine use, and cannabis use, who presents with digital clubbing and no apparent airway or cardiac disease?
What is the appropriate diagnosis and treatment approach for a patient with low albumin, elevated bilirubin, high alkaline phosphatase, and elevated aspartate aminotransferase (AST) levels indicating liver dysfunction?
Is dexamethasone (corticosteroid) suitable for an adult difficult intubation patient with a history of respiratory or anatomical issues and potential comorbidities such as diabetes and hypertension?
Is it safe for a patient with atrial fibrillation or deep vein thrombosis on anticoagulant therapy, such as warfarin, aspirin, apixaban, or rivaroxaban, to use Nattokinase?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.